Evaluation of a New Communication Aid Tool to Favor Global Patient Centered Care
Recruiting · NCT04179695 · Interventional (participants receive a specific treatment) · Lead sponsor: University Hospital, Lille
View the official record on ClinicalTrials.gov →Interventions studied
Consulting with PARKINSUN as communication aid-toolConsulting without PARKINSUN as communication aid-tool
What this trial is about
PARKINSUN is a new communication aid tool, expected to favor global patient centered care for PD patients during consultation with GPs and neurologists. Two groups of patients will be randomized to use or not PARKINSUN when they consult their physicians every 3 months during 7 months.
Who can take part
Age range
18 Years to 90 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Adult men and women with all stages of PD
- Without severe chronic neurological or mental or psychiatric pathology
- Absence of cognitive impairment affecting autonomy (MDS criteria of dementia and MOCA \> 22)
- able to come (alone or accompanied) to consultation
- Affiliate or beneficiary of a social security scheme
- Subject having signed informed consent
- Patient willing to comply with all procedures of the study and its duration
Exclusion criteria
- Administrative reasons: impossibility of receiving informed information, inability to participate in the whole study, absence of coverage by the social security system, refusal to sign consent.
- Subject under tutelage or curtailer.
- Subject not fluent in the French language to understand the instructions necessary to carry out the cognitive tests.
Where it is running
1 location listed.
- Hopital Roger Salengro, CHU Lille - Lille, France